Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:NVLS’

James Flynn Deerfield Management

13D Filing: James E. Flynn and Nivalis Therapeutics Inc. (NVLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 16 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)

This week was a good one for a few biotechs, but not so great for others. Two in particular have just put out news relating to trials for their lead investigative......(read more)
lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Here’s What Happens Now At Nivalis Therapeutics Inc (NVLS)

Nivalis Therapeutics Inc (NASDAQ:NVLS) is one of the first spectacular failure stories of 2017. The company announced data from its lead cystic fibrosis......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Should You Buy Nivalis Therapeutics Inc (NVLS)?

Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD)

It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at. It’s been......(read more)
CITADEL INVESTMENT GROUP

Ken Griffin And James Flynn Are Not Wasting Any Time Getting In On These New IPOs

Ken Griffin‘s (pictured) Citadel Investment Group has acquired about 1.09 million shares of 8Point3 Energy Partners LP (NASDAQ:CAFD). The holding......(read more)

Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)

Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E. Flynn‘s Deerfield Management, which was a stakeholder......(read more)